A new immunotherapy trial for the deadliest form of brain cancer, glioblastoma, is now recruiting patients after one individual experienced a remarkable outcome, seeing his tumour vanish.
The NHS study, set to enrol 16 people over an 18-month period, has been established in memory of Baroness Margaret McDonagh, who succumbed to the disease.